Kyowa Kirin Co., Ltd., Tokyo, Japan.
Parkinsonism Relat Disord. 2020 Nov;80 Suppl 1:S13-S20. doi: 10.1016/j.parkreldis.2020.09.025. Epub 2020 Dec 19.
Adenosine A receptor antagonism is a new therapeutic strategy in the symptomatic treatment of Parkinson's disease (PD). This review addresses how adenosine A receptors are involved with the control of motor function via the basal ganglia-thalamocortical circuit, and considers the anatomical localization and physiological function of the receptor, along with its ultrastructural localization in critical areas/neurons of the circuit. Based on this understanding of the functional significance of the adenosine A receptor in the basal ganglia, the mode of action of A receptor antagonists is explored in terms of the dynamic functioning of the basal ganglia and the activity of the internal circuits of the striatum in PD. Finally, the pathophysiological differences between the normal and PD states are examined to emphasize the importance of the adenosine A receptor.
腺苷 A 受体拮抗作用是治疗帕金森病(PD)症状的新策略。这篇综述探讨了腺苷 A 受体如何通过基底神经节-丘脑皮质回路控制运动功能,并考虑了受体的解剖定位和生理学功能,以及其在回路关键区域/神经元中的超微结构定位。基于对基底神经节中腺苷 A 受体功能意义的理解,根据基底神经节的动态功能以及 PD 中纹状体内部回路的活性,探讨了 A 受体拮抗剂的作用模式。最后,检查了正常和 PD 状态下的病理生理学差异,以强调腺苷 A 受体的重要性。